Loading...

Retractable Technologies, Inc.

RVPAMEX
Healthcare
Medical - Instruments & Supplies
$0.83
$-0.00(-0.42%)

Retractable Technologies, Inc. (RVP) Financial Performance & Income Statement Overview

Review Retractable Technologies, Inc. (RVP) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
-24.19%
24.19%
Operating Income Growth
-83.72%
83.72%
Net Income Growth
-69.54%
69.54%
Operating Cash Flow Growth
-517.70%
517.70%
Operating Margin
-58.08%
58.08%
Gross Margin
-6.86%
6.86%
Net Profit Margin
-22.90%
22.90%
ROE
-10.80%
10.80%
ROIC
-16.05%
16.05%

Retractable Technologies, Inc. (RVP) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Retractable Technologies, Inc. RVP financial performance.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$0.00$9.07M$10.35M$6.03M
Cost of Revenue$0.00$11.57M$10.36M$6.45M
Gross Profit-$1911.00-$2.49M-$14810.00-$419924.00
Gross Profit Ratio-$0.27-$0.001-$0.07
R&D Expenses$191192.00$157894.00$174695.00$199093.00
SG&A Expenses$4.48M$4.57M$4.95M$5.14M
Operating Expenses$4.67M$4.73M$5.12M$5.34M
Total Costs & Expenses$0.00$16.29M$15.48M$11.79M
Interest Income$0.00$145041.00$293550.00$244518.00
Interest Expense-$23455.00$26711.00$30489.00$31817.00
Depreciation & Amortization$0.00$1.89M$1.91M$1.89M
EBITDA-$4.68M$5.69M-$15877.00-$3.94M
EBITDA Ratio$0.63-$0.002-$0.65
Operating Income-$4.68M-$7.22M-$5.14M-$5.76M
Operating Income Ratio-$0.80-$0.50-$0.96
Other Income/Expenses (Net)-$5.54M$10.99M$3.18M-$92038.00
Income Before Tax-$10.21M$3.77M-$1.95M-$5.85M
Income Before Tax Ratio$0.42-$0.19-$0.97
Income Tax Expense$285761.00$1990.00-$31181.00$8.31M
Net Income-$10.50M$3.77M-$1.92M-$14.16M
Net Income Ratio$0.42-$0.19-$2.35
EPS-$0.35$0.13-$0.07-$0.48
Diluted EPS-$0.35$0.13-$0.07-$0.48
Weighted Avg Shares Outstanding$29.94M$29.94M$29.94M$29.94M
Weighted Avg Shares Outstanding (Diluted)$29.94M$29.94M$29.94M$29.94M

Financial performance has remained strong, with revenue growing from $6.03M in Q2 2024 to $0.00 in Q1 2025. Gross profit continued to perform well, with margins at N/A in the latest quarter. Operating income reached -$4.68M in Q1 2025, holding a steady N/A margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$4.68M. Net income dropped to -$10.50M, keeping EPS at -$0.35. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;